Skip to content

Author

Xiaoliang Deng

We have 1 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Imaging-guided COX-2 inhibition synergizes with photodynamic immunogenic cell death to potentiate checkpoint blockade in colon cancer

The findings elucidate the mechanism underlying the co-administration of VER and CXB, demonstrate the advantages of albumin as a superior drug carrier, and establish the combination of VC@HSA with ICB as a promising therapeutic strategy for colon cancer.

Lina Wu, Xi-Jun Chen, Jiao-Ling He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.